Raymond James Financial
TNDM icon

Raymond James Financial’s Tandem Diabetes Care TNDM Stock Holding History

Raymond James Financial’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Sell
122,021
-3,324
-3% -$58K ﹤0.01% 3543
2026
Q1 		$2.4M Buy
125,345
+5,176
+4% +$112K ﹤0.01% 3212
2025
Q4 		$2.64M Sell
120,169
-16,757
-12% -$302K ﹤0.01% 3054
2025
Q3 		$1.66M Sell
136,926
-6,348
-4% -$85.9K ﹤0.01% 3311
2025
Q2 		$2.67M Sell
143,274
-43,354
-23% -$859K ﹤0.01% 2845
2025
Q1 		$3.58M Buy
186,628
+23,014
+14% +$673K ﹤0.01% 2558
2024
Q4 		$5.89M Buy
+163,614
New +$5.53M ﹤0.01% 2217

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Raymond James Financial's TNDM Position: Q2 2026 in Review

Raymond James Financial reduced its Tandem Diabetes Care (TNDM) stake by 2.7% in Q2 2026, selling an estimated $58K and leaving 122,021 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3543.

Raymond James Financial first reported a position in TNDM in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.89M in Q4 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Raymond James Financial held 122,021 shares of Tandem Diabetes Care worth $1.84M as of Q2 2026.
  • Raymond James Financial sold 3,324 Tandem Diabetes Care shares in Q2 2026, an estimated $58K.
  • Tandem Diabetes Care made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3543 holding.
  • Raymond James Financial first reported a position in Tandem Diabetes Care in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Tandem Diabetes Care position peaked at $5.89M in Q4 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.